Skip to main content
Log in

A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

To develop non-invasive regional cerebral blood flow (rCBF) measurements using technetium-99m ethyl cysteinate dimer (99mTc-ECD) and single-photon emission tomography (SPET), the same graphical analysis as was described in our previous reports using technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) was applied to time-activity data for the aortic arch and brain hemispheres after intravenous injection of99mTc-ECD. Hemispherical brain perfusion indices (BPI) for99mTc-ECD showed a highly significant correlation (n = 22,r = 0.935,P = 0.0001) with those for99mTc-HMPAO in 11 patients who underwent both tracer studies. Using both linear regression line equations between99mTc-ECD BPI and99mTc-HMPAO BPI and between99mTc-HMPAO BPI and mean cerebral blood flow (CBF) values obtained from a xenon-133 inhalation SPET method in a previous study,99mTc-ECD BPI was converted to133Xe CBF values (y = 2.60x + 19.8). Then raw SPET images of99mTc-ECD were converted to rCBF maps using Lassen's correction algorithm. In this algorithm, the correction factor a was fixed to 1.5, 2.6 and infinite. In the comparison of rCBF values for99mTc-ECD SPET with those for99mTc-HMPAO SPET in 396 regions of interest in the aforementioned 11 patients, the fixed correction factor α of 2.6 gave nearly the same rCBF values for99mTc-ECD (50.1 ± 16.9 ml/100 g/min, mean ± SD) as for99mTc-HMPAO (49.9 ± 17.3 ml/100 g/min). In conclusion, the same non-invasive method as has been used in99mTc-HMPAO studies is applicable to a99mTc-ECD study for the measurement of rCBF without any blood sampling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan R, Goldsmith SJ. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.J Nucl Med 1989;30:599–604.

    PubMed  Google Scholar 

  2. Walovitch RC, Hill TC, Garrity ST, Cheesman EH, Burgess BA, O'Leary SH, Watson AD, Ganey WV, Morgan RA, Williams SJ. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging. Part 1. Pharmacology of technetium-99m ECD in nonhuman primates.J Nucl Med 1989;30: 1892–1901.

    PubMed  Google Scholar 

  3. Léveillé J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging. Part 2. Biodistribution and brain imaging in humans.J Nucl Med 1989;30:1902–1910.

    PubMed  Google Scholar 

  4. Léveillé J, Demonceau G, Walovitch RC. Intrasubject comparison between technetium-99m-ECD and technetium-99m HMPAO in healthy human subjects.J Nucl Med 1992;33: 480–484.

    PubMed  Google Scholar 

  5. Matsuda H, Li YM, Higashi S, Sumiya H, Tsuji S, Kinuya K, Hisada K, Yamashita J. Comparative SPECT study of stroke using Tc-99m ECD, I-123 IMP, and Tc-99m HMPAO.Clin Nucl Med 1993;18:754–758.

    PubMed  Google Scholar 

  6. Friberg L, Andersen AR, Lassen NA, Holm S, Dam M. Retention of99mTc-bicisate in the human brain after intracarotid injection.J Cereb Blood Flow Metab 1994;14 Suppl 1:S19-S27.

    PubMed  Google Scholar 

  7. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. A quantitative approach to technetium-99m hexamethylpropylene amine oxime.Eur J Nucl Med 1992;19:195–200.

    PubMed  Google Scholar 

  8. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.Eur J Nucl Med 1993;20:391–401.

    PubMed  Google Scholar 

  9. Lassen NA, Andersen AR, Friberg L, Paulson OB. The retention of [99mTc]-D,L-HMPAO in the human brain after intracarotid bolus injection: a kinetic analysis.J Cereb Blood Flow Metab 1988;8 Suppl 1: S44-S51.

    PubMed  Google Scholar 

  10. Andersen AR, Friberg H, Knudsen KBM, Barry DI, Paulson OB, Schmidt JF, Lassen NA, Neirinckx RD. Extraction of [99mTc]-d,l-HM-PAO across the blood-brain barrier.J Cereb Blood Flow Metab 1988;8 Suppl 1:544–851.

    Google Scholar 

  11. Peters AM. Graphical analysis of dynamic data: the Patlakand Rutland plot.Nucl Med Commun 1994;15:669–672.

    PubMed  Google Scholar 

  12. Knudsen GM, Andersen AR, Somnier FE, Videbwk C, Hasselbalch S, Paulson OB. Brain extraction and distribution of99mTc-bicisate in humans and rats.J Cereb Blood Flow Metab 1994;14 Suppl 1:S12-S18.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsuda, H., Yagishita, A., Tsuji, S. et al. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 22, 633–637 (1995). https://doi.org/10.1007/BF01254564

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01254564

Key words

Navigation